a clinical-stage biopharmaceutical company, which engages in the development of non-viral gene engineering technologies for the treatment of hematological malignancies and solid tumors
Industry Biotechnology
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
SGHIX | 10.80 | 0.01 | +0.09% |
Sextant Global High Income | |||
NMMEX | 15.02 | -0.04 | -0.27% |
Northern Active M Emerging Market Equity | |||
JEMKX | 9.47 | -0.06 | -0.63% |
JHancock Emerging Markets Equity R2 | |||
ASYMX | 14.72 | -0.22 | -1.47% |
Alger Weatherbie Specialized Growth Y | |||
ASLWX | 129.36 | -2.90 | -2.19% |
American Century Select Y |
A.I.dvisor indicates that over the last year, PSTX has been loosely correlated with NTLA. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if PSTX jumps, then NTLA could also see price increases.
Ticker / NAME | Correlation To PSTX | 1D Price Change % | ||
---|---|---|---|---|
PSTX | 100% | -14.02% | ||
NTLA - PSTX | 50% Loosely correlated | -7.61% | ||
ALEC - PSTX | 50% Loosely correlated | -17.21% | ||
QNRX - PSTX | 48% Loosely correlated | +2.17% | ||
EDIT - PSTX | 45% Loosely correlated | -3.97% | ||
INZY - PSTX | 43% Loosely correlated | -8.89% | ||
More |